These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 23590187

  • 1. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP, Vavia PR.
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [Abstract] [Full Text] [Related]

  • 2. Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study.
    Pagar KP, Vavia PR.
    Ther Deliv; 2013 May; 4(5):553-65. PubMed ID: 23647274
    [Abstract] [Full Text] [Related]

  • 3. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H, Zhong H, Liu M, Xu C, Gao Y.
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [Abstract] [Full Text] [Related]

  • 4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287
    [Abstract] [Full Text] [Related]

  • 5. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery.
    Doan TV, Couet W, Olivier JC.
    Int J Pharm; 2011 Jul 29; 414(1-2):112-7. PubMed ID: 21596123
    [Abstract] [Full Text] [Related]

  • 6. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 29; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]

  • 7. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
    Dhanaraju MD, Rajkannan R, Selvaraj D, Jayakumar R, Vamsadhara C.
    Contraception; 2006 Aug 29; 74(2):148-56. PubMed ID: 16860053
    [Abstract] [Full Text] [Related]

  • 8. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O, Serhatlı M, Baysal K, Baysal BM.
    J Microencapsul; 2011 Aug 29; 28(1):46-54. PubMed ID: 21171816
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y, Wang Y, Kang A, Wang W, Ho SV, Gao J, Ma G, Su Z.
    Mol Pharm; 2012 Jul 02; 9(7):2039-48. PubMed ID: 22663348
    [Abstract] [Full Text] [Related]

  • 11. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro.
    Lewis KJ, Irwin WJ, Akhtar S.
    J Drug Target; 1998 Jul 02; 5(4):291-302. PubMed ID: 9713978
    [Abstract] [Full Text] [Related]

  • 12. Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres.
    Akala EO, Wiriyacoonkasem P, Pan G.
    Drug Dev Ind Pharm; 2011 Jun 02; 37(6):673-84. PubMed ID: 21449706
    [Abstract] [Full Text] [Related]

  • 13. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation.
    Jiang Y, Wang F, Xu H, Liu H, Meng Q, Liu W.
    Int J Pharm; 2014 Nov 20; 475(1-2):475-84. PubMed ID: 25219858
    [Abstract] [Full Text] [Related]

  • 14. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H, Lu Y, Zhang G, Gao S, Sun D, Zhong Y.
    Int J Pharm; 2008 Mar 03; 351(1-2):244-9. PubMed ID: 18024022
    [Abstract] [Full Text] [Related]

  • 15. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.
    Song X, Song SK, Zhao P, Wei LM, Jiao HS.
    Pharm Dev Technol; 2013 Mar 03; 18(5):1220-9. PubMed ID: 22295954
    [Abstract] [Full Text] [Related]

  • 16. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J, Wu F, Cai Y, Xu M, He M, Yuan W.
    Eur J Pharm Sci; 2014 Oct 01; 62():141-7. PubMed ID: 24907681
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T.
    Int J Pharm; 2007 Apr 04; 334(1-2):137-48. PubMed ID: 17196348
    [Abstract] [Full Text] [Related]

  • 20. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies.
    Vora L, V G S, Vavia P.
    Eur J Pharm Sci; 2017 Sep 30; 107():78-86. PubMed ID: 28629804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.